Intensity Therapeutics is a biotechnology company whose mission is to greatly extend the lives of patients with cancer. The Company is using its proprietary DfuseRxSM platform technology to create novel immune-based therapeutic products for a new and emerging field of cancer treatment known as in situ vaccination.
Who we are
Intensity Therapeutics is a product development stage company. We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6.